drugset / Trial / NCT06956014

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

NCT06956014 ↗

Phase 3 Not yet recruiting 810 enrolled Vertanical GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.

Timeline

Start
2026-09
Primary completion
2028-09
Completion
2028-09

Drugs

EvaluationDrugModalityDoseRoute
Subject VER-01 Unknown 19 mg/ml —

Indications